|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Costs and expenses | ||||
| Cost of sales, exclusive of depreciation shown separately below | ||||
| Engineering | ||||
| Selling, general and administrative | ||||
| Research and development | ||||
| Depreciation expense | ||||
| Other operating expenses | ||||
| Total costs and expenses | ||||
| Operating loss | ||||
| Other income (expense), net | ||||
| Finance income (expense), net | ||||
| Interest income, net | ||||
| Change in fair value of financial instruments | ||||
| Loss on extinguishment of debt | ||||
| Other income, net | ||||
| Other income (expense), net | ||||
| Total other income (expense), net | ||||
| Loss before income tax | ||||
| Income tax expense | ||||
| Net loss available to stockholders | ||||
| Other comprehensive loss | ||||
| Foreign currency translation gain (loss), net of tax | ||||
| Comprehensive loss | ||||
| Basic and diluted earnings per share | ||||
| Basic net loss per share for the period attributable to holders of Common Stock (in dollars per share) | ||||
| Basic weighted-average Common Stock outstanding (in shares) | ||||
| Diluted net loss per share for the period attributable to holders of Common Stock (in dollars per share) | ||||
| Diluted weighted-average Common Stock outstanding (in shares) |
Loading...